Detalhe da pesquisa
1.
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network.
Gynecol Obstet Invest
; 83(5): 508-514, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738361
2.
Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
Int J Gynecol Cancer
; 27(3): 500-506, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187089
3.
The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.
Arch Gynecol Obstet
; 294(5): 889-895, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637583
4.
[Imaging of the pelvic floor : The gynaecological perspective]. / Bildgebung des Beckenbodens : Die Sicht der Gynäkologie.
Radiologie (Heidelb)
; 63(11): 821-826, 2023 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-37789193
5.
Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide.
Cancers (Basel)
; 15(7)2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046713
6.
Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer.
Anticancer Res
; 42(12): 5839-5845, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456138
7.
Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Histopathology
; 56(6): 727-39, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546338
8.
Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study.
Support Care Cancer
; 18(8): 931-42, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19760286
9.
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
Int J Cancer
; 125(6): 1454-63, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19533750
10.
Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study.
Cytokine
; 45(1): 8-11, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19071030
11.
New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
Crit Rev Oncol Hematol
; 67(3): 204-12, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18407513
12.
Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study.
Cancer Chemother Pharmacol
; 62(3): 393-400, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17922272
13.
Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.
Anticancer Res
; 28(2B): 1329-34, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18505074
14.
Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology.
Eur J Obstet Gynecol Reprod Biol
; 282: 61-63, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640696
15.
Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald.
Anticancer Res
; 38(3): 1539-1545, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29491083
16.
Functionality of the Tumor Suppressor microRNA-1 in Malignant Tissue and Cell Line Cells of Uterine Leiomyosarcoma.
Anticancer Res
; 38(3): 1547-1550, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29491084
17.
Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Gynecol Oncol
; 107(2): 266-73, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17698176
18.
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
Gynecol Oncol
; 107(3): 563-71, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17900673
19.
Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.
Anticancer Res
; 27(3B): 1527-30, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17595771
20.
The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.
Anticancer Res
; 27(3B): 1531-5, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17595772